KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Notes Payables (2016 - 2026)

Colgate Palmolive has reported Notes Payables over the past 18 years, most recently at $36.0 million for Q1 2026.

  • For Q1 2026, Notes Payables changed N/A year-over-year to $36.0 million; the TTM value through Mar 2026 reached $36.0 million, changed N/A, while the annual FY2025 figure was $1.1 billion, 69.24% up from the prior year.
  • Notes Payables for Q1 2026 was $36.0 million at Colgate Palmolive, down from $1.1 billion in the prior quarter.
  • Over five years, Notes Payables peaked at $1.6 billion in Q2 2025 and troughed at $7.0 million in Q1 2022.
  • A 5-year average of $407.1 million and a median of $183.0 million in 2023 define the central range for Notes Payables.
  • Biggest five-year swings in Notes Payables: crashed 97.24% in 2022 and later soared 2900.0% in 2023.
  • Year by year, Notes Payables stood at $11.0 million in 2022, then soared by 2900.0% to $330.0 million in 2023, then surged by 100.0% to $660.0 million in 2024, then surged by 69.24% to $1.1 billion in 2025, then crashed by 96.78% to $36.0 million in 2026.
  • Business Quant data shows Notes Payables for CL at $36.0 million in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.